Abstract
The alteration of amyloid precursor protein (APP) proteolysis is a hallmark of Alzheimers disease (AD). Recent studies have described noncanonical pathways of APP processing that seem partly executed by lysosomal enzymes. Our laboratorys in vitro human SK-N-MC model has shown that oxidative stress (OS) alters the lysosomal degradation pathway and the processing/metabolism of APP. The present study identifies the lysosomal protein matrix metalloproteinase 14 (MMP14) as a protease involved in the APP noncanonical processing. Previous expression analyses of the above cells showed MMP14 to be overexpressed under OS. In the present work, its role in changes in OS-induced APP proteolysis and lysosomal load was examined. The results show that MMP14 mediates the accumulation of an 85kDa N-terminal APP fragment and increases the lysosome load induced by OS. These results were validated in neurons and neural progenitor cells generated from the induced pluripotent stem cells of patients with sporadic AD, reinforcing the idea that MMP14 may offer a therapeutic target in this disease.
Funding Information
  • Medical Faculty of Heinrich Heine University, Duesseldorf, Germany (SAF2017-85747-R)
  • Banco de Santander to the Centro de Biología Molecular Severo Ochoa (SAF2017-85747-R)
  • Fundación Ramón Areces (SAF2017-85747-R)
  • Ministerio de Ciencia, Innovación y Universidades (SAF2017-85747-R)

This publication has 48 references indexed in Scilit: